Palo Alto, CA, United States of America

Khoa Dinh Nguyen

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Palo Alto, CA (US) (2019 - 2020)
  • Redwood City, CA (US) (2020 - 2021)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Khoa Dinh Nguyen: Innovator in Neurodegenerative Disease Treatment

Introduction

Khoa Dinh Nguyen is a prominent inventor based in Palo Alto, CA. He has made significant contributions to the field of neurodegenerative disease treatment through his innovative research and patented inventions. With a total of 7 patents, Nguyen is recognized for his work in developing compounds that activate Ppargc1a, which plays a crucial role in combating various neurodegenerative conditions.

Latest Patents

Nguyen's latest patents include groundbreaking compounds known as 2-arylbenzimidazoles. These compounds are designed as Ppargc1a activators for treating neurodegenerative diseases. The first patent discloses a genus of compounds encompassed by formula (III) that activate Ppargc1a, making them useful for treating a variety of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, Huntington's disease, frontotemporal degeneration, dementia with Lewy bodies, motor neuron diseases, and demyelinating diseases. The second patent focuses on the specific compound 2-(4-tert-Butylphenyl)-1H-benzo[d]imidazol-5-ol, which also activates Ppargc1a and is beneficial for treating neuroinflammation and various neurodegenerative diseases.

Career Highlights

Khoa Dinh Nguyen is affiliated with Leland Stanford Junior University, where he conducts his research and development work. His innovative approach and dedication to addressing neurodegenerative diseases have positioned him as a key figure in this critical area of medical research.

Collaborations

Nguyen has collaborated with notable colleagues, including Edgar George Engleman and Samuel D Banister. These partnerships have further enhanced his research efforts and contributed to the advancement of treatments for neurodegenerative diseases.

Conclusion

Khoa Dinh Nguyen's work in developing Ppargc1a activators represents a significant advancement in the treatment of neurodegenerative diseases. His innovative patents and collaborations highlight his commitment to improving the lives of those affected by these challenging conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…